Multi-Year Project to Analyze Largest Patient Safety Database in the Country and Use Innovative Approach to More Rapidly Identify Actionable Insights

Three-week June campaign successfully rallied blood donors to donate A, B, AB and O

New results from the NURTURE study demonstrate that pre-symptomatic infants treated with SPINRAZA are achieving motor milestones that are unprecedented in the natural history of the disease, including 100 percent of children sitting without support and 88 percent walking independently

Pilot study published in Journal of Pediatric Urology

CancerCare® has announced the publication of a patient manifesto, declaring the fundamental importance of including patients' values and priorities in cancer treatment planning.

IBE President Dr. Martin Brodie Receives Epilepsy Lifetime Accelerator Award at AEDD

Northwestern Medicine Lou and Jean Malnati Brain Tumor Institute of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University at Northwestern Memorial Hospital will hold its annual Minds Matter Benefit Dinner on Friday, May 17 at 6 p.m. for an evening to honor and support individuals affected by brain and spinal tumors. This year's theme is "Darkness to Light" and includes iconic Chicago television news anchor Robin Robinson who will serve as the master of ceremonies for the black-tie benefit dinner.

Obesity is One of the Largest Drivers of Preventable Chronic Disease; LeanMD's 360 Degree Solution is Medically Supervised, Pharmaceutically Enhanced, and Features Advancements in Healthcare

Renown Health, northern Nevada's healthcare leader and Reno's only locally owned not-for-profit health system, and Genome Medical, a leading nationwide telegenomics technology and services company, today announced a partnership to bring genetic counseling and educational services to participants of the Healthy Nevada Project.

Loopback Analytics, a leading provider of data-driven solutions for hospital and health systems, announced today it has partnered with The University of VermontMedical Center to help advance the network's specialty and ambulatory pharmacy services.

Azmi Nasser, D.O., Medical Director at Arizona Pain Treatment Centers in Arizona, sends his best regards to the patients and team affected from the closure of Laser Spine Institute (LSI) in Scottsdale, Arizona. Each patient preparing for surgery with LSI and now in need of care will be welcomed. Laser spine surgery is offered by Dr. Nasser and his team is here to help.

SaVida Health, a leader in outpatient medication-assisted treatment for opioid and alcohol addiction, is pleased to announce the opening of its treatment center in Front Royal, Virginia.

Novartis said its studies show that Cosentyx (secukinumab), formulated to treat psoriasis, psoriatic arthritis (PsA) and ankylosing spondylitis (AS), achieves clearer skin in subjects after 12 weeks compared to Stelara (ustekinumab).

Abelson Taylor and The Bloc are sponsoring the fifth annual Young Globals Student Competition & Internship, which will introduce students from design and technology institutions to careers in health care communications.

Risk greatest in people with later-stage cancers and lung and colon cancers

To Meet Burgeoning Need, RCA Adds a Third Center in New Jersey for Life-Saving Addiction Treatment Services

The University of Pittsburgh Medical Center's (UPMC) Hillman Cancer Center recently became the first cancer center in western Pennsylvania to offer immunotherapy for non-Hodgkin lymphoma cancer patients.

Guidelines focus on lifestyle and behavioral management, pharmacologic approaches, and strategies for avoiding and treating diabetes-related complications

ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic oligomers implicated in the development of neurodegenerative diseases, issued a narrated scientific white paper titled: “The critical importance of selectivity when developing antibody therapies for Alzheimer’s disease.”

The American Brain Tumor Association (ABTA), the nation's first nonprofit organization dedicated to brain tumor education and research, is now accepting Letters of Intent (LOI) for three research funding opportunities.